Look Ahead: Antimicrobial Resistance

Cures 2.0 Seen As Opportunity For Policies To Spur New Antibiotics

By Kelly Lienhard
January 13, 2020 at 12:45 PM
The Pew Charitable Trusts and other stakeholders working to stem antimicrobial resistance (AMR) view lawmakers’ plans for a second iteration of the 21 st Century Cures Act as an opportunity to enact policies to spur development of new antibiotics. They are looking to Cures 2.0 as a vehicle for new economic incentives to develop antibiotics, revamped reimbursement strategies, increased federal research funding, enhanced data sharing and new requirements to reduce use of antibiotics in humans. Increased resistance to antibiotics is...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.